Gufic Biosciences Limited (NSE:GUFICBIO)
India · Delayed Price · Currency is INR 475.40
+1.05 (0.22%)
Nov 11, 2026, 1:15 PM IST
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 47.78 billion as of November 10, 2026. Its market cap has increased by 50.18% in one year.
Market Cap
47.78B
Enterprise Value
51.21B
Revenue
9.81B
Global Rank
n/a
Country Rank
n/a
PE Ratio
64.93
ChartMarket Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 47.78B, an increase of 13,278.62%. That is a compound annual growth rate of 20.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 47.78B | 41.49% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Strides Pharma Science | 92.38B |
| Aarti Pharmalabs | 83.55B |
| Sun Pharma Advanced Research Company | 68.41B |
| Innova Captab | 61.17B |
| Orchid Pharma | 52.94B |
| RPG Life Sciences | 42.94B |
| Solara Active Pharma Sciences | 31.27B |
| Ind-Swift Laboratories | 30.35B |